Skip to content
bluejethealthcare.com
Home
About Us
At A Glance
Facilities
History
Sustainability
News And Media
Business Segments
Integrated Contrast Media Intermediate Manufacturer
Saccharin & it’s salts
Niche pharmaceutical intermediates & API
CDMO-CMO
Capabilities
EHS
Reaction Capabilities
R & D Capabilities
Manufacturing Capabilities
Contact
Careers
Investor Relations
Financial information
Annual Report
Annual Return
Corporate Governance
Board of Directors
Board Committees
Governance Policies
Familiarization Programmes
Draft letter of appointment of Independent Directors
Industry Reports
Investors Contact
Menu
Home
About Us
At A Glance
Facilities
History
Sustainability
News And Media
Business Segments
Integrated Contrast Media Intermediate Manufacturer
Saccharin & it’s salts
Niche pharmaceutical intermediates & API
CDMO-CMO
Capabilities
EHS
Reaction Capabilities
R & D Capabilities
Manufacturing Capabilities
Contact
Careers
Investor Relations
Financial information
Annual Report
Annual Return
Corporate Governance
Board of Directors
Board Committees
Governance Policies
Familiarization Programmes
Draft letter of appointment of Independent Directors
Industry Reports
Investors Contact
Consolidated Annual Report
Consolidated Annual Report
Consolidated Annual Report FY 20-21
Consolidated Annual Report FY 19-20
Standalone Annual Report
Standalone Annual report
Standalone Annual report FY 21-22
Standalone Annual Report FY 20-21
Standalone Annual Report FY 19-20
Scroll to Top
